Kemal Catakovic

552 total citations
7 papers, 349 citations indexed

About

Kemal Catakovic is a scholar working on Genetics, Immunology and Oncology. According to data from OpenAlex, Kemal Catakovic has authored 7 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Kemal Catakovic's work include Chronic Lymphocytic Leukemia Research (5 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Kemal Catakovic is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Kemal Catakovic collaborates with scholars based in Austria, United Kingdom and Slovakia. Kemal Catakovic's co-authors include Roland Geisberger, E. Klieser, Daniel Neureiter, Nadja Zaborsky, Franz Josef Gassner, Richard Greil, Stefan Rebhandl, Maria Schubert, Tanja Nicole Hartmann and Alexander Egle and has published in prestigious journals such as International Journal of Molecular Sciences, European Journal of Immunology and British Journal of Haematology.

In The Last Decade

Kemal Catakovic

7 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kemal Catakovic Austria	6	198	189	95	77	49	7	349
Franz Josef Gassner Austria	11	143 0.7×	178 0.9×	140 1.5×	181 2.4×	96 2.0×	31	398
Christian Sordo‐Bahamonde Spain	12	393 2.0×	440 2.3×	121 1.3×	60 0.8×	46 0.9×	24	659
D M Grote United States	8	263 1.3×	273 1.4×	147 1.5×	52 0.7×	153 3.1×	8	487
Sylvia Snauwaert Belgium	10	182 0.9×	108 0.6×	85 0.9×	55 0.7×	129 2.6×	34	324
Valentina Griggio Italy	10	144 0.7×	208 1.1×	75 0.8×	193 2.5×	90 1.8×	18	362
Ryota Kondou Japan	9	229 1.2×	186 1.0×	105 1.1×	50 0.6×	20 0.4×	18	358
Yao‐Hui Huang China	8	116 0.6×	86 0.5×	151 1.6×	34 0.4×	112 2.3×	16	299
Véronique Minard-Colin United States	5	156 0.8×	308 1.6×	59 0.6×	50 0.6×	66 1.3×	8	397
Alejandra Gutiérrez‐González Spain	9	121 0.6×	150 0.8×	121 1.3×	17 0.2×	22 0.4×	13	302
Sabrina Carpentier France	9	225 1.1×	372 2.0×	128 1.3×	36 0.5×	23 0.5×	11	573

Countries citing papers authored by Kemal Catakovic

Since Specialization

Citations

This map shows the geographic impact of Kemal Catakovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kemal Catakovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kemal Catakovic more than expected).

Fields of papers citing papers by Kemal Catakovic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kemal Catakovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kemal Catakovic. The network helps show where Kemal Catakovic may publish in the future.

Co-authorship network of co-authors of Kemal Catakovic

This figure shows the co-authorship network connecting the top 25 collaborators of Kemal Catakovic. A scholar is included among the top collaborators of Kemal Catakovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kemal Catakovic. Kemal Catakovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

Gassner, Franz Josef, M. Steiner, Kemal Catakovic, et al.. (2021). Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia. International Journal of Molecular Sciences. 22(13). 6648–6648. 3 indexed citations

Egle, Alexander, Michael Steurer, Thomas Melchardt, et al.. (2018). Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study. Annals of Hematology. 97(10). 1825–1839. 9 indexed citations

Gassner, Franz Josef, Maria Schubert, Stefan Rebhandl, et al.. (2017). Imprecision and DNA Break Repair Biased towards Incompatible End Joining in Leukemia. Molecular Cancer Research. 16(3). 428–438. 79 indexed citations

Catakovic, Kemal, E. Klieser, Daniel Neureiter, & Roland Geisberger. (2017). T cell exhaustion: from pathophysiological basics to tumor immunotherapy. Cell Communication and Signaling. 15(1). 1–1. 149 indexed citations

Catakovic, Kemal, Franz Josef Gassner, Nadja Zaborsky, et al.. (2017). TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia. OncoImmunology. 7(1). e1371399–e1371399. 64 indexed citations

Gassner, Franz Josef, Nadja Zaborsky, Kemal Catakovic, et al.. (2015). Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the TCL1 transgenic mouse model. British Journal of Haematology. 170(4). 515–522. 39 indexed citations

Rebhandl, Stefan, Michael Huemer, Nadja Zaborsky, et al.. (2014). Alternative splice variants of AID are not stoichiometrically present at the protein level in chronic lymphocytic leukemia. European Journal of Immunology. 44(7). 2175–2187. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact